Online citations, reference lists, and bibliographies.
← Back to Search

MDR3 P-glycoprotein, A Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs And Directly Interacts With Drugs As Judged By Interference With Nucleotide Trapping*

A. Smith, A. van Helvoort, G. van Meer, K. Szabó, E. Welker, G. Szakács, A. Váradi, B. Sarkadi, P. Borst
Published 2000 · Biology, Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The human MDR3 gene is a member of the multidrug resistance (MDR) gene family. The MDR3 P-glycoprotein is a transmembrane protein that translocates phosphatidylcholine. The MDR1 P-glycoprotein related transports cytotoxic drugs. Its overexpression can make cells resistant to a variety of drugs. Attempts to show that MDR3 P-glycoprotein can cause MDR have been unsuccessful thus far. Here, we report an increased directional transport of several MDR1 P-glycoprotein substrates, such as digoxin, paclitaxel, and vinblastine, through polarized monolayers of MDR3-transfected cells. Transport of other good MDR1 P-glycoprotein substrates, including cyclosporin A and dexamethasone, was not detectably increased. MDR3 P-glycoprotein-dependent transport of a short-chain phosphatidylcholine analog and drugs was inhibited by several MDR reversal agents and other drugs, indicating an interaction between these compounds and MDR3 P-gp. Insect cell membranes from Sf9 cells overexpressing MDR3 showed specific MgATP binding and a vanadate-dependent,N-ethylmaleimide-sensitive nucleotide trapping activity, visualized by covalent binding with [α-32P]8-azido-ATP. Nucleotide trapping was (nearly) abolished by paclitaxel, vinblastine, and the MDR reversal agents verapamil, cyclosporin A, and PSC 833. We conclude that MDR3 P-glycoprotein can bind and transport a subset of MDR1 P-glycoprotein substrates. The rate of MDR3 P-glycoprotein-mediated transport is low for most drugs, explaining why this protein is not detectably involved in multidrug resistance. It remains possible, however, that drug binding to MDR3 P-glycoprotein could adversely affect phospholipid or toxin secretion under conditions of stress (e.g. in pregnant heterozygotes with oneMDR3 null allele).
This paper references
10.1139/O59-099
A rapid method of total lipid extraction and purification.
E. G. Bligh (1959)
10.1016/0092-8674(86)90595-7
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
C. Chen (1986)
10.1002/j.1460-2075.1987.tb02653.x
The human mdr3 gene encodes a novel P‐glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver.
A. M. van der Bliek (1987)
10.1016/0378-1119(88)90057-1
Sequence of mdr3 cDNA encoding a human P-glycoprotein.
A. M. van der Bliek (1988)
Genes amplified and overexpressed in human multidrug-resistant cell lines.
A. M. van der Bliek (1988)
10.1128/MCB.8.7.2770
Cloning and characterization of a second member of the mouse mdr gene family.
P. Gros (1988)
10.1038/SCIENTIFICAMERICAN0389-44
Multidrug resistance in cancer.
N. Kartner (1989)
10.1021/BI00461A013
Expression of the human multidrug transporter in insect cells by a recombinant baculovirus.
U. Germann (1990)
10.1073/PNAS.87.1.152
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.
E. Georges (1990)
10.1093/JNCI/82.13.1133
Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
H. Herweijer (1990)
10.1016/0006-291X(90)91928-L
Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter.
Shoichiro Tanaka (1990)
10.1128/MCB.10.4.1642
Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.
M. Raymond (1990)
10.1002/IJC.2910450409
Expression of the mdr3 gene in prolymphocytic leukemia: Association with cyclosporin‐a‐induced increase in drug accumulation
K. Nooter (1990)
10.1016/s0021-9258(19)67788-4
Structure of the human MDR3 gene and physical mapping of the human MDR locus.
C. Lincke (1991)
Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
A. Schinkel (1991)
10.1128/MCB.11.2.595
Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes.
E. Buschman (1991)
10.1002/JCP.1041520112
Reduced mRNA levels for the multidrug‐resistance genes in cAMP‐dependent protein kinase mutant cell lines
K. Chin (1992)
10.1016/s0021-9258(18)35757-0
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
K. Ueda (1992)
10.1016/s0021-9258(18)42909-2
Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.
B. Sarkadi (1992)
Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
Y. Tanigawara (1992)
Contribution of MDR3 P-gp to Transport of Cytotoxic Drugs
Y. Tanigawara (1992)
10.1016/0092-8674(93)90380-9
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
J.J.M. Smit (1993)
10.1016/s0021-9258(18)53199-9
N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
A. Schinkel (1993)
10.1016/0165-6147(94)90322-0
A mechanism for P-glycoprotein action in multidrug resistance: are we there yet?
S. Ruetz (1994)
Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.
T. H. Mauad (1994)
10.1016/0092-8674(94)90446-4
Phosphatidylcholine translocase: A physiological role for the mdr2 gene
S. Ruetz (1994)
10.1016/s0021-9258(17)42093-x
Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells. Evidence for the reverse action of a sphingomyelin synthase.
A. van Helvoort (1994)
10.1073/PNAS.91.19.8822
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
G. Zaman (1994)
10.1016/0014-5793(94)01135-4
The human MDR3 P‐glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
Alexander J. Smith (1994)
The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein.
E. Buschman (1994)
10.1074/JBC.270.33.19383
P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site (*)
I. Urbatsch (1995)
10.1172/JCI118214
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
A. Schinkel (1995)
10.1074/jbc.270.43.25388
Enhancement of Mdr2-mediated Phosphatidylcholine Translocation by the Bile Salt Taurocholate
S. Ruetz (1995)
10.1083/JCB.131.3.645
Differential targeting of glucosylceramide and galactosylceramide analogues after synthesis but not during transcytosis in Madin-Darby canine kidney cells.
I. L. V. Genderen (1995)
10.1074/jbc.270.45.26956
Both P-glycoprotein Nucleotide-binding Sites Are Catalytically Active (*)
I. Urbatsch (1995)
10.1146/ANNUREV.GE.29.120195.003135
Genetic analysis of the multidrug transporter.
M. Gottesman (1995)
10.1016/S0092-8674(00)81370-7
MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine
A. V. Helvoort (1996)
10.1016/S0014-5793(96)01265-3
Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P‐glycoproteins
Kouichi Kino (1996)
10.1016/0959-8049(96)00057-3
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
U. Germann (1996)
10.1172/JCI118535
Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.
R. Evers (1996)
10.1083/JCB.132.5.813
Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells
P. van der Bijl (1996)
10.1002/CHIN.199642292
Multidrug Resistance of Cancer Cells
S. Kane (1996)
10.1006/JTBI.1996.0183
Control analysis of biliary lipid secretion.
A. Groen (1996)
10.1073/PNAS.94.8.4028
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
A. Schinkel (1997)
10.1172/JCI119784
Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
U. Mayer (1997)
10.1172/JCI119799
Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.
A. Crawford (1997)
10.1074/jbc.273.17.10132
Drug-stimulated Nucleotide Trapping in the Human Multidrug Transporter MDR1
K. Szabó (1998)
10.1093/JNCI/90.15.1161
Availability of PSC833, a Substrate and Inhibitor of P-glycoproteins, in Various Concentrations of Serum
A. Smith (1998)
10.1002/HEP.510280234
Hepatocyte‐specific expression of the human MDR3P‐glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (−/−) mice
Alexander J. Smith (1998)
10.1073/PNAS.95.1.282
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
J. M. de Vree (1998)
10.1016/S0140-6736(05)77221-4
Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
E. Jacquemin (1999)
The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane.
R. Raggers (1999)



This paper is referenced by
10.1016/j.jlr.2021.100087
Monomeric bile acids modulate the ATPase activity of detergent-solubilized ABCB4/MDR3
T. Kroll (2021)
10.1242/jeb.232272
CRISPR/Cas9 mutagenesis reveals a role for ABCB1 in gut immune responses to Vibrio diazotrophicus in sea urchin larvae.
Travis J Fleming (2021)
10.1016/j.str.2021.05.013
Evidence for a credit-card-swipe mechanism in the human PC floppase ABCB4.
Martin Prescher (2021)
10.1016/j.pharmthera.2020.107542
Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.
J. Beaudoin (2020)
10.1016/j.jhep.2020.04.036
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
A. Stättermayer (2020)
10.1016/j.jhep.2020.12.010
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4−/− mouse model of PFIC3
Guangyan Wei (2020)
10.1002/1873-3468.13972
Looking back at multidrug resistance (MDR) research and ten mistakes to be avoided when writing about ABC transporters in MDR
P. Borst (2020)
10.1515/hsz-2018-0441
ABCB4/MDR3 in health and disease – at the crossroads of biochemistry and medicine
Martin Prescher (2019)
10.1007/s13577-019-00261-5
Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells
Kyoko Tanaka (2019)
10.1038/s41594-019-0354-3
Structure of the human lipid exporter ABCB4 in a lipid environment
J. A. Olsen (2019)
10.1080/17425255.2019.1631285
What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs
O. Briz (2019)
10.1016/j.aohep.2019.09.010
ABCB4 disease: Many faces of one gene deficiency.
E. Sticova (2019)
10.1134/S0006297918080047
Structure and Function of Multidrug Resistance Protein 1
E. N. Yakusheva (2018)
10.1007/s00280-018-3603-y
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro
Jia-feng Huang (2018)
10.1055/s-0038-1667299
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
M. Reichert (2018)
10.1002/9781119282594.CH6
Transporters in Hepatotoxicity
Eleni Kotsampasakou (2018)
10.1016/j.drudis.2017.01.007
Models for drug absorption from the small intestine: where are we and where are we going?
Pierre-André Billat (2017)
10.3390/molecules22060871
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
S. Dewanjee (2017)
10.1016/j.cbpc.2017.02.004
Upregulating Nrf2-dependent antioxidant defenses in Pacific oysters Crassostrea gigas: Investigating the Nrf2/Keap1 pathway in bivalves.
N. M. Danielli (2017)
10.1097/CAD.0000000000000455
Reversal effects of local anesthetics on P-glycoprotein-mediated cancer multidrug resistance
Yong Hu (2017)
UvA-DARE ( Digital Academic Repository ) ABC transporters in Arthropods : genomic comparison and role in insecticide transport and resistance
Dermauw (2017)
10.1159/000484612
A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations
M. Cardoso (2017)
10.18632/oncotarget.9415
Down-regulation of ABCG2 and ABCB4 transporters in the placenta of rats exposed to cadmium
L. Liu (2016)
10.3929/ETHZ-A-010784145
Role of MDR3 in drug-induced cholestatic liver injury
Z. Mahdi (2016)
10.1124/mol.116.103390
Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis
Z. Mahdi (2016)
10.1093/humupd/dmv049
ATP-binding cassette transporters in reproduction: a new frontier.
E. Bloise (2016)
10.1111/bcp.13008
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity
F. Aminkeng (2016)
10.1016/j.reprotox.2016.04.017
Maternal-fetal transfer of indocyanine green across the perfused human placenta.
Miriam Rubinchik-Stern (2016)
Hepatotoxicidad: patrón colestásico inducido por fármacos Hepatotoxicity: A Drug-Induced Cholestatic Pattern
Laura Morales (2016)
10.1038/srep26872
Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3
H. J. Park (2016)
Hepatotoxicity : A Drug-Induced Cholestatic Pattern
L. Morales (2016)
10.1080/09168451.2014.993358
Position 834 in TM6 plays an important role in cholesterol and phosphatidylcholine transport by ABCA1
Shimpei Itoh (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar